{"64093":{"#nid":"64093","#data":{"type":"external_news","title":"Levine on Uncertain Stem Cell Policy","body":[{"value":"\u003Cp\u003E\u0022Frequent policy changes and uncertainty over future policy have been a near constant for stem-cell researchers over the last decade or so,\u0022 says Aaron Levine, Assistant Professor of Public Policy, about his research findings. Levine continues, \u0022That has affected both scientists studying embryonic stem cells and those working on less controversial cell types, who we might expect not to be as affected.\u0022 \u003Cem\u003ESource: Technology Review - February 3, 2011\u003C\/em\u003E\u003C\/p\u003E\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.technologyreview.com\/biomedicine\/32255\/page1\/\u0022\u003ERead full article\u003C\/a\u003E\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":"","field_summary_sentence":"","uid":"27418","created_gmt":"2011-02-04 15:14:20","changed_gmt":"2016-10-08 02:24:18","author":"Lauren Langley","boilerplate_text":"","field_publication":"","publication":"CREST D-Map","field_article_url":"","publication_url":"http:\/\/www.technologyreview.com\/biomedicine\/32255\/page1\/","dateline":{"date":"2011-02-03T00:00:00-05:00","iso_date":"2011-02-03T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"groups":[{"id":"1281","name":"Ivan Allen College of Liberal Arts"}],"categories":[{"id":"134","name":"Student and Faculty"}],"keywords":[{"id":"9555","name":"aaron levine"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}},"63104":{"#nid":"63104","#data":{"type":"news","title":"States Now Fund Majority of Human Embryonic Stem Cell Research","body":[{"value":"\u003Cp\u003EStates, not the federal government, now fund the majority of\nhuman embryonic stem cell research conducted in the United States, according to\na recent study in the journal Nature Biotechnology.\u0026nbsp; In addition, states varied substantially in\nthe extent to which they prioritized human embryonic stem cell research, and\nmuch of the research performed in the states could likely have been funded by\nthe National Institutes of Health under federal guidelines established by\nPresident Bush in 2001. \u003C\/p\u003E\n\n\n\n\u003Cp\u003E\u201cWhile the federal government still contributes more to stem\ncell research overall, each year since 2007 these six states have funded more\nhuman embryonic stem cell research than the federal government,\u201d said Aaron\nLevine, assistant professor at Georgia Tech. \u003C\/p\u003E\n\n\n\n\u003Cp\u003ELevine created an online searchable database (\u003Ca href=\u0022http:\/\/www.stemcellstates.net\/\u0022\u003Ehttp:\/\/www.stemcellstates.net\/\u003C\/a\u003E) that\nallows users to find detailed information about each grant given out by the six\nstates that adopted programs specifically to fund stem cell research. The\ndatabase currently covers grants given out by California, Connecticut,\nIllinois, Maryland, New Jersey and New York from December 2005 to December 2009,\nand will be updated yearly with new information.\u003C\/p\u003E\n\n\n\n\u003Cp\u003E\u201cFrom what I could tell, only a relatively small portion of\nthe stem cell research supported by these states was clearly ineligible for\nfederal funding,\u201d said Levine, who is on the faculty of the School of Public\nPolicy in the Ivan Allen College of Liberal Arts.\u003C\/p\u003E\n\n\n\n\u003Cp\u003ELevine reasons this could be a result of the fact that there\nare many incentives for scientists to work with existing human embryonic stem\ncell lines rather than creating new ones. \u003C\/p\u003E\n\n\n\n\u003Cp\u003EHe said he was surprised at how great the difference was\namong states in the share of grants that supported human embryonic stem cell\nresearch. While Connecticut and California devoted 97 percent and 75 percent of\ntheir grants to this research, New Jersey and New York steered only 21 percent\nto this contentious field. \u003C\/p\u003E\n\n\n\n\u003Cp\u003EOne reason for these differences may be the development of\ninduced pluripotent stem cells, which are derived from adult body cells rather\nthan from embryos.\u0026nbsp; More recent programs,\nsuch as New York\u2019s, may be disproportionally focusing on this new technology.\u003C\/p\u003E\n\n\n\n\n\n\u003Cp\u003E\u201cThere\u2019s no question that these\nstate programs drew a lot of scientists into the field,\u201d said Levine.\u0026nbsp; \u201cAn interesting question going forward is how\ncommitted these scientists are to stem cell research or if they are relating\ntheir work to stem cells now simply to be eligible for state funding \u2013 that\u2019s\nunknown right now.\u201d\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EStates, not the federal government, now fund the majority of\nhuman embryonic stem cell research conducted in the United States, according to\na study by Aaron Levine in the journal Nature Biotechnology.\u0026nbsp; In addition, much of the research performed\nin the states could likely have been funded by the National Institutes of\nHealth under federal guidelines established by President Bush in 2001.\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"Aaron Levine created an online searchable database showing funding information from the six states that adopted stem cell research programs."}],"uid":"27310","created_gmt":"2010-12-09 09:34:26","changed_gmt":"2016-10-08 03:07:54","author":"David Terraso","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2010-12-09T00:00:00-05:00","iso_date":"2010-12-09T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"58921":{"id":"58921","type":"image","title":"Dr. Aaron Levine","body":null,"created":"1449176204","gmt_created":"2015-12-03 20:56:44","changed":"1475894517","gmt_changed":"2016-10-08 02:41:57","alt":"Dr. Aaron Levine","file":{"fid":"190783","name":"tpb15085.jpg","image_path":"\/sites\/default\/files\/images\/tpb15085_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tpb15085_0.jpg","mime":"image\/jpeg","size":35289,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tpb15085_0.jpg?itok=pzt1U1lx"}},"63103":{"id":"63103","type":"image","title":"State Stem Cell Programs v. Federal Programs","body":null,"created":"1449176649","gmt_created":"2015-12-03 21:04:09","changed":"1475894552","gmt_changed":"2016-10-08 02:42:32","alt":"State Stem Cell Programs v. Federal Programs","file":{"fid":"191732","name":"Levine_NBT_Figure1.gif","image_path":"\/sites\/default\/files\/images\/Levine_NBT_Figure1_0.gif","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/Levine_NBT_Figure1_0.gif","mime":"image\/gif","size":28815,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Levine_NBT_Figure1_0.gif?itok=25PA4Gqq"}},"63102":{"id":"63102","type":"image","title":"State Stem Cell Programs","body":null,"created":"1449176649","gmt_created":"2015-12-03 21:04:09","changed":"1475894552","gmt_changed":"2016-10-08 02:42:32","alt":"State Stem Cell Programs","file":{"fid":"191731","name":"Screen_shot_2010-12-08_at_12.18.33_PM.png","image_path":"\/sites\/default\/files\/images\/Screen_shot_2010-12-08_at_12.18.33_PM_0.png","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/Screen_shot_2010-12-08_at_12.18.33_PM_0.png","mime":"image\/png","size":134239,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/Screen_shot_2010-12-08_at_12.18.33_PM_0.png?itok=sdHKTPZZ"}}},"media_ids":["58921","63103","63102"],"groups":[{"id":"1183","name":"Home"}],"categories":[{"id":"146","name":"Life Sciences and Biology"}],"keywords":[{"id":"949","name":"ivan allen"},{"id":"8996","name":"levine"},{"id":"626","name":"public policy"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EGeorgia Tech Media Relations\u003C\/strong\u003E\u003Cbr \/\u003ELaura Diamond\u003Cbr \/\u003E\u003Ca href=\u0022mailto:laura.diamond@comm.gatech.edu\u0022\u003Elaura.diamond@comm.gatech.edu\u003C\/a\u003E\u003Cbr \/\u003E404-894-6016\u003Cbr \/\u003EJason Maderer\u003Cbr \/\u003E\u003Ca href=\u0022mailto:maderer@gatech.edu\u0022\u003Emaderer@gatech.edu\u003C\/a\u003E\u003Cbr \/\u003E404-660-2926\u003C\/p\u003E","format":"limited_html"}],"email":["david.terraso@comm.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"62741":{"#nid":"62741","#data":{"type":"news","title":"GA. in Stem Cell Focus","body":[{"value":"\u003Cp\u003EIt was a matter of horrible happenstance that brought the first human trial involving embryonic stem cells to Atlanta this month. \n\u003C\/p\u003E\n\u003Cp\u003ETeams at both Atlanta\u2019s Shepherd Center and Northwestern University in Chicago were standing by to begin the historic trial, each awaiting a newly injured patient. Sometime in the 14 days before Oct. 8, someone, presumably in the South, suffered a paralyzing spine injury, signed the papers and became Patient A. \n\u003C\/p\u003E\n\u003Cp\u003EThe procedure occurred at Piedmont Hospital, which adjoins Shepherd. The patient\u2019s name, age and sex are unknown. The news \u2014 abhorrent in some quarters, thrilling in others \u2014 immediately spread worldwide, seemingly thrusting Atlanta into the biomedical spotlight. \n\u003C\/p\u003E\n\u003Cp\u003EBut the choice of an Atlanta institution to play a part in the landmark study was no accident. A confluence of factors has turned Georgia into a top-tier state for biotech research and development. There are learning centers such as Georgia Tech, the University of Georgia and Emory University, a pro-business climate that includes top-notch hospitals and the utility of Hartsfield-Jackson International Airport, among others. \n\u003C\/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022http:\/\/www.ajc.com\/health\/ga-in-stem-cell-684287.html\u0022\u003ERead Full Article\u003C\/a\u003E\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EIt was a matter of horrible happenstance that brought the first human trial involving embryonic stem cells to Atlanta this month. \n\nTeams at both Atlanta\u2019s Shepherd Center and Northwestern University in Chicago were standing by to begin the historic trial, each awaiting a newly injured patient. Sometime in the 14 days before Oct. 8, someone, presumably in the South, suffered a paralyzing spine injury, signed the papers and became Patient A.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"GA. in Stem Cell Focus"}],"uid":"27349","created_gmt":"2010-10-19 00:00:00","changed_gmt":"2016-10-08 03:07:46","author":"Floyd Wood","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2010-10-17T00:00:00-04:00","iso_date":"2010-10-17T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"66537":{"id":"66537","type":"image","title":"Embryonic stem cells are a blank slate having the potential to turn into cells that build parts of the body. Their use is also among the nation\u0027s -- and Georgia\u0027s -- most hot-button political issues.","body":null,"created":"1449177176","gmt_created":"2015-12-03 21:12:56","changed":"1475894592","gmt_changed":"2016-10-08 02:43:12","alt":"Embryonic stem cells are a blank slate having the potential to turn into cells that build parts of the body. Their use is also among the nation\u0027s -- and Georgia\u0027s -- most hot-button political issues.","file":{"fid":"192571","name":"embryonic_stem_cells.jpg","image_path":"\/sites\/default\/files\/images\/embryonic_stem_cells_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/embryonic_stem_cells_0.jpg","mime":"image\/jpeg","size":5939,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/embryonic_stem_cells_0.jpg?itok=iqFIbOe4"}}},"media_ids":["66537"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"139","name":"Business"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"},{"id":"145","name":"Engineering"},{"id":"149","name":"Nanotechnology and Nanoscience"},{"id":"135","name":"Research"},{"id":"150","name":"Physics and Physical Sciences"}],"keywords":[{"id":"109","name":"Georgia Tech"},{"id":"1487","name":"GTEC"},{"id":"248","name":"IBB"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EFloyd Wood\u003C\/strong\u003E\u003Cbr \/\u003EIBB\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=fwood3\u0022\u003EContact Floyd Wood\u003C\/a\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["floyd.wood@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"60431":{"#nid":"60431","#data":{"type":"news","title":"NSF Awards $3M Stem Cell Bio-Manufacturing Program to Georgia Tech","body":[{"value":"\u003Cp\u003EThe National Science Foundation (NSF) has awarded $3 million to the Georgia Institute of Technology to fund a unique research program on stem cell bio-manufacturing. The program is specifically focused on developing engineering methods for stem cell production, in order to meet the anticipated demand for stem cells. The award comes through the NSF\u0027s Integrative Graduate Education and Research Traineeship (IGERT) Program, which supports innovation in graduate education in fields that cross academic disciplines and have broad societal impact.\u003C\/p\u003E\u003Cp\u003EWhile stem cell research is on the verge of broadly impacting many elements of the medical field -- regenerative medicine, drug discovery and development, cell-based diagnostics and cancer -- the bio-process engineering that will be required to manufacture sufficient quantities of functional stem cells for these diagnostic and therapeutic purposes has not been rigorously explored. \u003C\/p\u003E\u003Cp\u003E\u0022Successfully integrating knowledge of stem cell biology with bioprocess engineering and process development into single individuals is the challenging goal of this program,\u0022 said Todd McDevitt, an associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University and a Petit Faculty Fellow in the Parker H. Petit Institute for Bioengineering and Biosciences at Georgia Tech. \u003C\/p\u003E\u003Cp\u003EMcDevitt is leading the IGERT with Robert M. Nerem, professor emeritus of the George W. Woodruff School of Mechanical Engineering at Georgia Tech. Nerem is also director of the Georgia Tech\/Emory Center (GTEC) for Regenerative Medicine, which will administer this award.\u003C\/p\u003E\u003Cp\u003EPh.D. students funded by Georgia Tech\u0027s stem cell bio-manufacturing IGERT will receive interdisciplinary educational training in the biology, engineering, enabling technologies, commercialization and public policy related to stem cells. Their research efforts will focus on developing innovative engineering approaches to bridge the gap between basic discoveries made in stem cell biology and therapeutic stem cell-based technologies. \u003C\/p\u003E\u003Cp\u003E\u0022This program provides a unique opportunity for engineers to generate standardized and quantitative methods for stem cell isolation, characterization, propagation and differentiation,\u0022 said Nerem. \u0022These techniques must be developed in a scalable manner to efficiently produce sufficient numbers of stem cells and derivatives in accessible formats in order to yield a spectrum of novel therapeutic and diagnostic applications of stem cells.\u0022 \u003C\/p\u003E\u003Cp\u003EThe Georgia Tech program is centered around three main research thrusts, which focus on several critical technologies that must be developed to enable the application and use of stem cell-based products: \u003C\/p\u003E\u003Cp\u003E\u2022 Creating reproducible, controlled and scalable methods to expand and differentiate stem cells with defined phenotypes and epigenetic states. \u003C\/p\u003E\u003Cp\u003E\u2022 Developing reliable, rapid and quantifiable methods to characterize the composition and function of stem cells to be generated. \u003C\/p\u003E\u003Cp\u003E\u2022 Designing low-cost systems capable of producing large populations of defined stem cells and derivatives.\u003C\/p\u003E\u003Cp\u003EStudents in the program will be able to take advantage of the core facilities provided by the new Stem Cell Engineering Center at Georgia Tech, which is directed by McDevitt. Technologies developed by the students supported through this IGERT will be rapidly integrated into academic and industrial stem cell practices and cell-based products. \u003C\/p\u003E\u003Cp\u003EThe award will support 30 new Ph.D. students over the next five years and brings together more than two dozen faculty members from Georgia Tech, Emory University, the University of Georgia and the Morehouse School of Medicine. In addition, plans are being made for students to participate in international research collaborations with the National University of Ireland at Galway, Imperial College London, the University of Cambridge and the University of Toronto. \u003C\/p\u003E\u003Cp\u003E\u0022We anticipate this program will produce the future leaders and innovators in the field of stem cell bio-manufacturing who will contribute significantly at the interface of stem cell engineering, biology and therapy,\u0022 added McDevitt. \u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EResearch News \u0026amp; Publications Office\u003Cbr \/\u003EGeorgia Institute of Technology\u003Cbr \/\u003E75 Fifth Street, N.W., Suite 314\u003Cbr \/\u003EAtlanta, Georgia 30308 USA \u003C\/strong\u003E Abby Vogel Robinson (404-385-3364; \u003Ca href=\u0022mailto:abby@innovate.gatech.edu\u0022\u003Eabby@innovate.gatech.edu\u003C\/a\u003E) or John Toon (404-894-6986; \u003Ca href=\u0022mailto:jtoon@gatech.edu\u0022\u003Ejtoon@gatech.edu\u003C\/a\u003E) \u003C\/p\u003E\u003Cp\u003EMedia Relations Contacts:\u003C\/p\u003E\u003Cp\u003E\u003Cstrong\u003EWriter:\u003C\/strong\u003E Abby Vogel Robinson\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Nerem and McDevitt will lead Integrative Graduate Education and Research Traineeship (IGERT) Program"}],"field_summary":[{"value":"\u003Cp\u003EThe NSF has awarded $3 million to Georgia Tech to fund a unique research program on stem cell bio-manufacturing. The effort is focused on developing engineering methods for stem cell production to meet the anticipated demand for stem cells.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"A stem cell bio-manufacturing research and education program award has been awarded to Georgia Tech."}],"uid":"27206","created_gmt":"2010-08-15 00:00:00","changed_gmt":"2016-10-08 03:07:15","author":"Abby Vogel Robinson","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2010-08-16T00:00:00-04:00","iso_date":"2010-08-16T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"60432":{"id":"60432","type":"image","title":"Todd McDevitt","body":null,"created":"1449176267","gmt_created":"2015-12-03 20:57:47","changed":"1475894523","gmt_changed":"2016-10-08 02:42:03","alt":"Todd McDevitt","file":{"fid":"191123","name":"tnh17927.jpg","image_path":"\/sites\/default\/files\/images\/tnh17927_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tnh17927_0.jpg","mime":"image\/jpeg","size":1233833,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tnh17927_0.jpg?itok=vgTJzXrP"}},"60433":{"id":"60433","type":"image","title":"Robert Nerem","body":null,"created":"1449176267","gmt_created":"2015-12-03 20:57:47","changed":"1475894523","gmt_changed":"2016-10-08 02:42:03","alt":"Robert Nerem","file":{"fid":"191124","name":"tao17927.jpg","image_path":"\/sites\/default\/files\/images\/tao17927_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tao17927_0.jpg","mime":"image\/jpeg","size":1376960,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tao17927_0.jpg?itok=cUXTKsm5"}},"60434":{"id":"60434","type":"image","title":"Robert Nerem \u0026 Todd McDevitt","body":null,"created":"1449176267","gmt_created":"2015-12-03 20:57:47","changed":"1475894523","gmt_changed":"2016-10-08 02:42:03","alt":"Robert Nerem \u0026 Todd McDevitt","file":{"fid":"191125","name":"tpb17928.jpg","image_path":"\/sites\/default\/files\/images\/tpb17928_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tpb17928_0.jpg","mime":"image\/jpeg","size":1599704,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tpb17928_0.jpg?itok=qHDHZJYj"}}},"media_ids":["60432","60433","60434"],"related_links":[{"url":"http:\/\/www.me.gatech.edu\/faculty\/nerem.shtml","title":"Robert Nerem"},{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=78","title":"Todd McDevitt"},{"url":"http:\/\/www.me.gatech.edu\/","title":"George W. Woodruff School of Mechanical Engineering"},{"url":"http:\/\/www.bme.gatech.edu\/","title":"Wallace H. Coulter Department of Biomedical Engineering"}],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"140","name":"Cancer Research"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"167413","name":"Stem Cell"},{"id":"171009","name":"stem cell bio-manufacturing"},{"id":"171010","name":"Stem Cell Development"},{"id":"169496","name":"stem cell differentiation"},{"id":"171011","name":"stem cell industry"},{"id":"171012","name":"stem cell production"},{"id":"167139","name":"Stem Cell Research"},{"id":"171013","name":"stem cell therapy"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EAbby Vogel Robinson\u003C\/strong\u003E\u003Cbr \/\u003EResearch News and Publications\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=avogel6\u0022\u003EContact Abby Vogel Robinson\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-3364\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["abby@innovate.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"48923":{"#nid":"48923","#data":{"type":"news","title":"Delivering Stem Cells Improves Repair of Major Bone Injuries in Rats","body":[{"value":"\u003Cp\u003EA study published this week reinforces the potential value of stem cells in repairing major injuries involving the loss of bone structure.  \u003C\/p\u003E\n\u003Cp\u003EThe study shows that delivering stem cells on a polymer scaffold to treat large areas of missing bone leads to improved bone formation and better mechanical properties compared to treatment with the scaffold alone. This type of therapeutic treatment could be a potential alternative to bone grafting operations.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022Massive bone injuries are among the most challenging problems that orthopedic surgeons face, and they are commonly seen as a result of accidents as well as in soldiers returning from war,\u0022 said the study\u0027s lead author Robert Guldberg, a professor in Georgia Tech\u0027s Woodruff School of Mechanical Engineering. \u0022This study shows that there is promise in treating these injuries by delivering stem cells to the injury site. These are injuries that would not heal without significant medical intervention.\u0022\n\u003C\/p\u003E\n\u003Cp\u003EDetails of the research were published in the early edition of the journal \u003Cem\u003EProceedings of the National Academy of Sciences\u003C\/em\u003E on January 11, 2010. This work was funded by the National Institutes of Health and the National Science Foundation.\n\u003C\/p\u003E\n\u003Cp\u003EThe study was conducted in rats in which two bone gaps eight millimeters in length were created to simulate massive injuries. One gap was treated with a polymer scaffold seeded with stem cells and the other with scaffold only. The results showed that injuries treated with the stem cell scaffolds showed significantly more bone growth than injuries treated with scaffolds only. \n\u003C\/p\u003E\n\u003Cp\u003EGuldberg and mechanical engineering graduate student Kenneth Dupont experimented with scaffolds containing two different types of human stem cells -- bone marrow-derived mesenchymal adult stem cells and amniotic fluid fetal stem cells. \n\u003C\/p\u003E\n\u003Cp\u003E\u0022We were able to directly evaluate the therapeutic potential of human stem cells to repair large bone defects by implanting them into rats with a reduced immune system,\u0022 explained Guldberg, who is also the director of the Petit Institute for Bioengineering and Bioscience at Georgia Tech.\u003C\/p\u003E\n\u003Cp\u003EMicro-CT measurements showed no significant differences in bone regeneration between the two stem cell groups. However, combining the two types of stem cells produced significantly higher bone volume and strength compared to scaffolds without cellular augmentation.\n\u003C\/p\u003E\n\u003Cp\u003EAlthough stem cell delivery significantly enhanced bone growth and biomechanical properties, it was not able to consistently repair the injury. Eight weeks after the treatment, new bone bridged the gaps in four of nine defects treated with scaffolds seeded with adult stem cells, one of nine defects treated with scaffolds seeded with fetal stem cells, and none of the defects treated with the scaffold alone.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022We thought that the functional regeneration of the bone defects may have been limited by stem cells migrating away from the injury site, so we decided to investigate the fate and distribution of the delivered cells,\u0022 said Guldberg.\n\u003C\/p\u003E\n\u003Cp\u003ETo do this, Guldberg labeled stem cells with fluorescent quantum dots -- nanometer-scale particles that emit light when excited by near-infrared radiation -- to track the distribution of stem cells after delivery on the scaffolds and completed the same experiments as previously described. \n\u003C\/p\u003E\n\u003Cp\u003EThroughout the entire study, the researchers observed significant fluorescence at the stem cell scaffold sites. However, beginning seven to 10 days after treatment, signals appeared at the scaffold-only sites. Additional analysis with immunostaining revealed that the quantum dots present at the scaffold-only sites were contained in inflammatory cells called macrophages that had taken up quantum dots released from dead stem cells.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022While our overall study shows that stem cell therapy has a lot of promise for treating massive bone defects, this experiment shows that we still need to develop an improved way of delivering the stem cells so that they stay alive longer and thus remain at the injury site longer,\u0022 explained Guldberg.\u003C\/p\u003E\n\u003Cp\u003EThe researchers also found that the quantum dots diminished the function of the transplanted stem cells and thus their therapeutic effect. When the stem cells were labeled with quantum dots, the results showed a failure to enhance bone formation or bridge defects. However, the same low concentration of quantum dots did not affect cell viability or the ability of the stem cells to become bone cells in laboratory studies. \n\u003C\/p\u003E\n\u003Cp\u003E\u0022Although in vitro laboratory studies remain important, this work provides further evidence that well-characterized in vivo models are necessary to test the ability of regenerative tissue strategies to effectively integrate and restore function in complex living organisms,\u0022 added Guldberg. \u0022Improved methods of non-invasive cell tracking that do not alter cell function in vivo are needed to optimize stem cell delivery strategies and compare the effectiveness of different stem cell sources for tissue regeneration.\u0022\n\u003C\/p\u003E\n\u003Cp\u003EGuldberg is currently exploring alternative cell tracking methods, such as genetically modifying the stem cells to express green fluorescent protein and\/or other luminescent enzymes such as luciferase. He is also investigating the addition of programming cues to the scaffold that will direct the stem cells to differentiate into bone cells. These signals may be particularly effective for fetal stem cells, which are believed to be more primitive than adult stem cells, according to Guldberg. \n\u003C\/p\u003E\n\u003Cp\u003ELessons learned from the current work are also being applied to develop effective stem cell therapies for severe composite injuries to multiple tissues including bone, nerve, vasculature and muscle. This follow-on work is being conducted in the Georgia Tech Center for Advanced Bioengineering for Soldier Survivability in collaboration with Ravi Bellamkonda and Barbara Boyan, professors in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.\n\u003C\/p\u003E\n\u003Cp\u003EOther authors on the paper include Andres Garcia, professor and Woodruff Faculty Fellow in Georgia Tech\u0027s Woodruff School of Mechanical Engineering and the Petit Institute for Bioengineering and Bioscience; Georgia Tech research scientist Hazel Stevens, Georgia Tech graduate student Joel Boerckel; and National University of Ireland medical student Kapil Sharma.\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cem\u003EThis work was funded by grant number R01-AR051336 from the National Institutes of Health (NIH) and by grant number EEC-9731643 from the National Science Foundation (NSF). The content is solely the responsibility of the principal investigator and does not necessarily represent the official views of the NIH or NSF.\u003C\/em\u003E\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EResearch News \u0026amp; Publications Office\u003Cbr \/\u003E\nGeorgia Institute of Technology\u003Cbr \/\u003E\n75 Fifth Street, N.W., Suite 314\u003Cbr \/\u003E\nAtlanta, Georgia  30308  USA\n\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EMedia Relations Contacts:\u003C\/strong\u003E Abby Vogel (avogel@gatech.edu; 404-385-3364) or John Toon (jtoon@gatech.edu; 404-894-6986).\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EWriter:\u003C\/strong\u003E Abby Vogel\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"A new study published this week shows that delivering stem cells on a polymer scaffold to treat large areas of missing bone leads to improved bone formation and better mechanical properties compared to treatment with scaffold alone.","format":"limited_html"}],"field_summary_sentence":[{"value":"Study reinforces potential value of stem cells to repair bone in"}],"uid":"27206","created_gmt":"2010-01-11 01:00:00","changed_gmt":"2016-10-08 03:04:04","author":"Abby Vogel Robinson","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2010-01-11T00:00:00-05:00","iso_date":"2010-01-11T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"48924":{"id":"48924","type":"image","title":"Robert Guldberg bone regeneration","body":null,"created":"1449175408","gmt_created":"2015-12-03 20:43:28","changed":"1475894463","gmt_changed":"2016-10-08 02:41:03","alt":"Robert Guldberg bone regeneration","file":{"fid":"101291","name":"try39853.jpg","image_path":"\/sites\/default\/files\/images\/try39853_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/try39853_0.jpg","mime":"image\/jpeg","size":1255705,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/try39853_0.jpg?itok=V0huypJw"}},"48925":{"id":"48925","type":"image","title":"Bone regeneration with stem cell scaffold","body":null,"created":"1449175408","gmt_created":"2015-12-03 20:43:28","changed":"1475894463","gmt_changed":"2016-10-08 02:41:03","alt":"Bone regeneration with stem cell scaffold","file":{"fid":"101292","name":"tyd39853.jpg","image_path":"\/sites\/default\/files\/images\/tyd39853_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tyd39853_0.jpg","mime":"image\/jpeg","size":405535,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tyd39853_0.jpg?itok=SU7f1o5P"}},"48926":{"id":"48926","type":"image","title":"Robert Guldberg bone regeneration","body":null,"created":"1449175408","gmt_created":"2015-12-03 20:43:28","changed":"1475894463","gmt_changed":"2016-10-08 02:41:03","alt":"Robert Guldberg bone regeneration","file":{"fid":"101293","name":"the39853.jpg","image_path":"\/sites\/default\/files\/images\/the39853_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/the39853_0.jpg","mime":"image\/jpeg","size":1050118,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/the39853_0.jpg?itok=crlQN6aN"}}},"media_ids":["48924","48925","48926"],"related_links":[{"url":"http:\/\/www.me.gatech.edu\/faculty\/guldberg.shtml","title":"Robert Guldberg"},{"url":"http:\/\/www.me.gatech.edu\/","title":"George W. Woodruff School of Mechanical Engineering"},{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"}],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"145","name":"Engineering"},{"id":"135","name":"Research"}],"keywords":[{"id":"8233","name":"amniotic fluid fetal stem cells"},{"id":"530","name":"bone"},{"id":"8227","name":"bone defect"},{"id":"8231","name":"Bone Marrow Derived Stem Cells"},{"id":"8226","name":"Bone Regeneration"},{"id":"8225","name":"Bone Repair"},{"id":"8232","name":"fetal stem cells"},{"id":"6891","name":"fluorescence"},{"id":"8230","name":"Mesenchymal Stem Cells"},{"id":"8228","name":"Orthopedics"},{"id":"8229","name":"polymer scaffold"},{"id":"2363","name":"quantum dots"},{"id":"1489","name":"Regenerative Medicine"},{"id":"167413","name":"Stem Cell"},{"id":"167139","name":"Stem Cell Research"},{"id":"167130","name":"Stem Cells"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EAbby Vogel\u003C\/strong\u003E\u003Cbr \/\u003EResearch News and Publications\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=avogel6\u0022\u003EContact Abby Vogel\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-3364\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["avogel@gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56470":{"#nid":"56470","#data":{"type":"news","title":"McDevitt Named 2010 Young Investigator for SFB","body":[{"value":"\u003Cp\u003ETodd C. McDevitt, PhD, has been awarded the 2010 Young Investigator Award from the Society of Biomaterials. The Young Investigator Award recognizes an individual each year who has demonstrated outstanding achievements and leadership in the field of biomaterials research. Dr. McDevitt will receive the award at the 2010 Annual Meeting to be held in Seattle, WA, next April where he will also be provided the opportunity to address the whole society.\u003Cbr \/\u003E This marks the fourth time in the last seven years that a Georgia Tech faculty member has received the SFB Young Investigator award. Niren Murthy (BME) received the award in 2008, Julia Babensee (BME) in 2005 and Andr\u00e9s Garc\u00eda (ME) in 2004.\u003C\/p\u003E\u003Cp\u003EThe McDevitt Laboratory for the Engineering of Stem Cell Technologies is focused on the development and application of engineering principles to translate the potential of stem cells into viable regenerative therapies and in vitro diagnostics. Biomaterials-based approaches are used to engineer the microenvironment of stem cells in order to improve the efficiency and homogeneity of directed stem cell differentiation strategies. In addition, the McDevitt laboratory\u2019s research focuses on development of novel regenerative molecular therapies from natural biomaterials produced by stem cells. The combination of directed stem cell differentiation and development of stem cell-derived biomaterials is expected to yield fresh insights into stem cell biology, facilitate new regenerative therapies, and create novel cell diagnostic platforms. The McDevitt laboratory research is supported by funding from the National Institutes of Health, National Science Foundation, American Heart Association, and the Georgia Research Alliance, among others.\u003C\/p\u003E\u003Cp\u003EIn addition to the being named the 2010 Society for Biomaterials Young Investigator, McDevitt was appointed as a Petit Faculty Fellow in the Institute for Bioengineering and Bioscience in September 2009 and named the Director of the new Stem Cell Engineering Center at Georgia Tech, which is scheduled to officially launch in 2010. The establishment of the first center of its kind in the United States will bring together expertise from different engineering disciplines to address key technical challenges that currently limit the translation of stem cells and to innovate new technologies that will enhance basic stem cell research. The center will include Georgia Tech faculty from the College of Engineering, College of Sciences, and Ivan Allen College, in addition to collaborative partnerships with stem cell researchers at the University of Georgia, Emory University and other partnering institutions throughout the state of Georgia.\u003C\/p\u003E\u003Cp\u003ESince August of 2004, McDevitt has been an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology \/ Emory University. McDevitt graduated cum laude with a Bachelor of Science in Engineering (BSE) from Duke University in 1997 with a double major in Electrical Engineering and Biomedical Engineering. He received his Ph.D. from the University of Washington in Bioengineering in 2001 working in the laboratory of Patrick Stayton, Ph.D., on protein engineering, micropatterning and tissue engineering. From 2002-04, McDevitt conducted post-doctoral research in Chuck Murry\u0027s lab in the Department of Pathology at the University of Washington where he focused on mechanisms of stem cell growth and differentiation for myocardial repair.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003ETodd C. McDevitt, PhD, has been awarded the 2010 Young Investigator Award from the Society of Biomaterials. The Young Investigator Award recognizes an individual each year who has demonstrated outstanding achievements and leadership in the field of biomaterials research.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"McDevitt Named 2010 Young Investigator for SFB"}],"uid":"27224","created_gmt":"2009-12-15 01:00:00","changed_gmt":"2016-10-08 03:06:11","author":"Megan McDevitt","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-12-15T00:00:00-05:00","iso_date":"2009-12-15T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"related_links":[{"url":"http:\/\/mcdevitt.bme.gatech.edu\/","title":"Visit the McDevitt Lab- Engineering Stem Cell Technologies"},{"url":"http:\/\/www.ibb.gatech.edu\/","title":"Petit Institute for Bioengineering and Bioscience"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"130","name":"Alumni"},{"id":"129","name":"Institute and Campus"},{"id":"139","name":"Business"},{"id":"140","name":"Cancer Research"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"},{"id":"153","name":"Computer Science\/Information Technology and Security"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"147","name":"Military Technology"},{"id":"149","name":"Nanotechnology and Nanoscience"},{"id":"135","name":"Research"},{"id":"150","name":"Physics and Physical Sciences"}],"keywords":[{"id":"249","name":"Biomedical Engineering"},{"id":"516","name":"engineering"},{"id":"6217","name":"McDevitt"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Cstrong\u003EColly Mitchell\u003C\/strong\u003E\u003Cbr \/\u003EInstitute for Bioengineering and Bioscience\u003Cbr \/\u003E\u003Ca href=\u0022mailto:colly.mitchell@ibb.gatech.edu\u0022\u003EContact Colly Mitchell\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-894-5982\u003C\/strong\u003E\u003C\/p\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56467":{"#nid":"56467","#data":{"type":"news","title":"New Stem Cell Lines Approved for Tax-paid Research","body":[{"value":"\u003Cp\u003E\u003Cem\u003EBy LAURAN NEERGAARD - The Associated Press\u003C\/em\u003E \n\u003C\/p\u003E\n\u003Cp\u003EWASHINGTON \u2014 Scientists can start using taxpayer dollars to do research with 13 batches of embryonic stem cells and the government says dozens more cell lines should be available soon, opening a new era for the potentially life-saving field.\n\u003C\/p\u003E\n\u003Cp\u003EPresident Barack Obama lifted eight years of restrictions on these master cells last spring. But $21 million-and-counting in new projects were on hold until the National Institutes of Health determined which of hundreds of existing stem cell lines were ethically appropriate to use.\n\u003C\/p\u003E\n\u003Cp\u003E\u003Ca href=\u0027http:\/\/www.ajc.com\/news\/nation-world\/new-stem-cell-lines-222526.html\u0027\u003EFull article\u003C\/a\u003E\n\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"Scientists can start using taxpayer dollars to do research with 13 batches of embryonic stem cells and the government says dozens more cell lines should be available soon, opening a new era for the potentially life-saving field.","format":"limited_html"}],"field_summary_sentence":[{"value":"New Stem Cell Lines Approved for Tax-paid Research"}],"uid":"27195","created_gmt":"2009-12-04 01:00:00","changed_gmt":"2016-10-08 03:06:11","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-12-02T00:00:00-05:00","iso_date":"2009-12-02T00:00:00-05:00","tz":"America\/New_York"},"extras":[],"hg_media":{"56468":{"id":"56468","type":"image","title":"tqu04840.jpg","body":null,"created":"1449175653","gmt_created":"2015-12-03 20:47:33","changed":"1475894501","gmt_changed":"2016-10-08 02:41:41","alt":"","file":{"fid":"190480","name":"tqu04840.jpg","image_path":"\/sites\/default\/files\/images\/tqu04840_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tqu04840_0.jpg","mime":"image\/jpeg","size":6136,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tqu04840_0.jpg?itok=g4LWmjxg"}}},"media_ids":["56468"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"131","name":"Economic Development and Policy"},{"id":"140","name":"Cancer Research"},{"id":"135","name":"Research"}],"keywords":[{"id":"2276","name":"embryonic stem cells"},{"id":"1290","name":"federal funding"},{"id":"248","name":"IBB"},{"id":"167413","name":"Stem Cell"},{"id":"9564","name":"tax paid research"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EColly Mitchell\u003C\/strong\u003E\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=cmitchell6\u0022\u003EContact Colly Mitchell\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-894-5982\u003C\/strong\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56455":{"#nid":"56455","#data":{"type":"news","title":"Delivery of Adult Versus Fetal Stem Cells for Bone Regeneration","body":[{"value":"\u003Cp\u003E\u003Cstrong\u003EEngineered Delivery of Adult Versus Fetal Stem Cells for Bone Regeneration\u003C\/strong\u003E\n\u003C\/p\u003E\n\u003Cp\u003EAlexandra Peister and her collaborators received an NIH program project grant which will support research at Morehouse, Georgia Institute of Technology, University of Rochester, Emory University, and the University of Queensland in Australia. The grant will be funded for the next two years and will support research at Morehouse at a level of $36,000 per year. Co-Investigator, NIH Challenge Grant (American Recovery and Reinvestment Act funded): Engineered Delivery of Adult Versus Fetal Stem Cells for Bone Regeneration in collaboration with Georgia Tech. The grant will be funded September 2009.\n\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"Alexandra Peister and her collaborators received an NIH program project grant which will support research at Morehouse, Georgia Institute of Technology, University of Rochester, Emory University, and the University of Queensland in Australia.","format":"limited_html"}],"field_summary_sentence":[{"value":"Delivery of Adult Versus Fetal Stem Cells for Bone Regeneration"}],"uid":"27349","created_gmt":"2009-10-14 00:00:00","changed_gmt":"2016-10-08 03:06:11","author":"Floyd Wood","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-10-14T00:00:00-04:00","iso_date":"2009-10-14T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"56456":{"id":"56456","type":"image","title":"Dr. Alexandra Peister","body":null,"created":"1449175653","gmt_created":"2015-12-03 20:47:33","changed":"1475894501","gmt_changed":"2016-10-08 02:41:41","alt":"Dr. Alexandra Peister","file":{"fid":"190475","name":"tor48197.jpg","image_path":"\/sites\/default\/files\/images\/tor48197_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tor48197_0.jpg","mime":"image\/jpeg","size":31305,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tor48197_0.jpg?itok=o-sEj3UK"}}},"media_ids":["56456"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"},{"id":"145","name":"Engineering"},{"id":"135","name":"Research"}],"keywords":[{"id":"8226","name":"Bone Regeneration"},{"id":"247","name":"Emory"},{"id":"109","name":"Georgia Tech"},{"id":"9556","name":"Morehouse College"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EFloyd Wood\u003C\/strong\u003E\u003Cbr \/\u003EIBB\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=fwood3\u0022\u003EContact Floyd Wood\u003C\/a\u003E","format":"limited_html"}],"email":["floyd.wood@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56406":{"#nid":"56406","#data":{"type":"news","title":"Labs report progress in regrowing bones","body":[{"value":"\u003Cp\u003EATLANTA \u2014 As military doctors in Iraq and Afghanistan have seen more horrific injuries involving skin, nerve, vascular and bone losses from explosions, they have tried to think of what more could be done for the victims besides bandaging things up and hoping for the best.\n\u003C\/p\u003E\n\u003Cp\u003EMaybe they could regrow the tissue: Grow the cartilage, grow the blood vessels, grow the nerves and even grow the bone. \n\u003C\/p\u003E\n\u003Cp\u003E\u003Ca href=\u0027http:\/\/www.armytimes.com\/news\/2009\/10\/marine_bone_101109w\/\u0027\u003EView full article\u003C\/a\u003E\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"ATLANTA \u2014 As military doctors in Iraq and Afghanistan have seen more horrific injuries involving skin, nerve, vascular and bone losses from explosions, they have tried to think of what more could be done for the victims besides bandaging things up and hoping for the best.","format":"limited_html"}],"field_summary_sentence":[{"value":"Labs report progress in regrowing bones"}],"uid":"27224","created_gmt":"2009-10-12 00:00:00","changed_gmt":"2016-10-08 03:06:06","author":"Megan McDevitt","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-10-12T00:00:00-04:00","iso_date":"2009-10-12T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"134","name":"Student and Faculty"}],"keywords":[{"id":"535","name":"boyan"},{"id":"6973","name":"Guldberg"},{"id":"9524","name":"orthopedic"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EMegan McDevitt\u003C\/strong\u003E\u003Cbr \/\u003EIBB\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=mm504\u0022\u003EContact Megan McDevitt\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-7001\u003C\/strong\u003E","format":"limited_html"}],"email":["megan.mcdevitt@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56421":{"#nid":"56421","#data":{"type":"news","title":"McDevitt and Nerem Discuss Georgia Stem Cell Research Debate","body":[{"value":"\u003Cp\u003E\u0022Cell Division\u0022\u003Cbr \/\u003E\nGeorgia Trend -  September 2009\n\u003C\/p\u003E\n\u003Cp\u003E.. . It\u2019s a debate fraught with irony. Georgia has some of the nation\u2019s leading researchers in the area of embryonic stem cells, scientists recruited and paid for by the state as eminent scholars; and state leadership has identified the life sciences as a strategic industry of interest. And yet, many of Georgia\u2019s elected officialshave made it clear that they do not want new research in embryonic stem cells happening in Georgia,... \u201cInduced pluripotent cells are a great success story, but it\u2019s owed wholly to the fact that we had a starting basis in embryonic stem cells,\u201d says Todd McDevitt, a Georgia Tech scientist who directs stem cell technology research in his lab and focuses most of his attention on ES cells... For Georgia Tech professor Bob Nerem, research needs to move forward in all areas.  \u201cAt some point we will know about what makes the most sense from a patient point of view,\u201d says Nerem, director of both the Parker H. Petit Institute for Bioengineering and Bioscience at Tech, and the Georgia Tech-Emory Collabora-tion for Regenerative Medicine (GTEC)...  But for a young scientist like Todd McDevitt, whose lab at Georgia Tech has attracted some $2 million in federal funds and employs 10 other researchers, a differing opinion that has the potential to criminalize his work forces him to consider other options.\n\u003C\/p\u003E\n\u003Cp\u003E\u003Ca href=\u0027http:\/\/georgiatrend.com\/cover-story\/09_09_stemcell.shtml\u0027\u003EFull article\u003C\/a\u003E \n\u003C\/p\u003E\n\u003Cp\u003E\u003Ca href=\u0027http:\/\/mcdevitt.bme.gatech.edu\u0027\u003EMcDevitt lab\u003C\/a\u003E\n\u003C\/p\u003E\n\u003Cp\u003E\u003Ca href=\u0027http:\/\/www.ibb.gatech.edu\/about\/nerem.php\u0027\u003ENerem lab\u003C\/a\u003E\n\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"Todd McDevitt, PhD, and Bob Nerem, PhD, discuss Georgia debate regarding stem cell research in Georgia Trends article.","format":"limited_html"}],"field_summary_sentence":[{"value":"McDevitt and Nerem Discuss Georgia Stem Cell Research Debate"}],"uid":"27195","created_gmt":"2009-09-03 00:00:00","changed_gmt":"2016-10-08 03:06:06","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-09-01T00:00:00-04:00","iso_date":"2009-09-01T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"56422":{"id":"56422","type":"image","title":"Georgia debates stem cell research","body":null,"created":"1449175629","gmt_created":"2015-12-03 20:47:09","changed":"1475894501","gmt_changed":"2016-10-08 02:41:41","alt":"Georgia debates stem cell research","file":{"fid":"190467","name":"tlh49182.jpg","image_path":"\/sites\/default\/files\/images\/tlh49182_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tlh49182_0.jpg","mime":"image\/jpeg","size":50180,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tlh49182_0.jpg?itok=S0LlQdr5"}}},"media_ids":["56422"],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"140","name":"Cancer Research"},{"id":"141","name":"Chemistry and Chemical Engineering"},{"id":"134","name":"Student and Faculty"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"900","name":"Bob Nerem"},{"id":"342","name":"Georgia"},{"id":"109","name":"Georgia Tech"},{"id":"248","name":"IBB"},{"id":"167413","name":"Stem Cell"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EColly Mitchell\u003C\/strong\u003E\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=cmitchell6\u0022\u003EContact Colly Mitchell\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-894-5982\u003C\/strong\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"46312":{"#nid":"46312","#data":{"type":"news","title":"New Center Aims to Improve Recovery of Soldiers with Severe Injuries","body":[{"value":"\u003Cp\u003EWhen a soldier is wounded during combat, surgeons must focus on reducing infection and reconstructing damaged bone and tissues. Technologies that could improve the repair and regeneration processes are being developed in research laboratories across the country, but they are not being moved quickly enough into military trauma centers.\u003C\/p\u003E\n\u003Cp\u003EOrganizers of the recently established Georgia Tech Center for Advanced Bioengineering for Soldier Survivability want to change that.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022The goal of the center is to rapidly move new technologies from the laboratory to patients so that we can improve the quality of life for our veterans as they return from the wars the United States is fighting,\u0022 said center director Barbara Boyan, the Price Gilbert, Jr. Chair in Tissue Engineering at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.\n\u003C\/p\u003E\n\u003Cp\u003EThe center will leverage the expertise of Georgia Tech researchers in musculoskeletal biology and regenerative medicine to quickly move tools that are clinically valuable, safe and effective from laboratories to use in trauma centers. To reduce the amount of time from invention to clinical use, engineers and scientists in the center work in teams that include a clinician with experience in combat medical care and a medical device industry partner. \n\u003C\/p\u003E\n\u003Cp\u003ESupport for the center is provided by the Armed Forces Institute of Regenerative Medicine, the U.S. Army Institute of Surgical Research\u0027s Orthopedic Trauma Research Program, the U.S. Department of Defense and industry.\u003C\/p\u003E\n\u003Cp\u003EResearchers in the center will initially focus on ways to improve the healing of wounds, segmental bone defects and massive soft tissue defects. Traumatic injuries that affect the arms, legs, head and neck require technologies for treatment at the time of injury and in the ensuing days and months.  \n\u003C\/p\u003E\n\u003Cp\u003E\u0022These combat injuries are complicated to treat because they are large and typically infected, so even determining when a soldier should be treated for optimal recovery is a challenge,\u0022 said Boyan, who is also the associate dean for research in Georgia Tech\u0027s College of Engineering and a Georgia Research Alliance Eminent Scholar. \u0022It is not known whether a regenerative therapy will be most effective if used immediately following injury or at some later time after scar tissue has been established at the wound site.\u0022\n\u003C\/p\u003E\n\u003Cp\u003EBy developing models that accurately reflect the complex aspects of injuries sustained by soldiers in combat, the researchers will be able to test assumptions about when to employ specific strategies and how to ensure their effectiveness. The models must also allow them to examine the use of technologies on both male and female patients, and on complex tissues that consist of nerves, a blood supply and multiple cell types.  \n\u003C\/p\u003E\n\u003Cp\u003E\u0022Since the processes of bone, vascular and neural formation are naturally linked during normal tissue development, growth and repair, our approach is to harness this knowledge by developing delivery strategies that present the right biologic cues in the right place at the right time to promote functional regeneration of multiple integrated tissues,\u0022 said associate director of the center Robert Guldberg, a professor in Georgia Tech\u0027s Woodruff School of Mechanical Engineering.\n\u003C\/p\u003E\n\u003Cp\u003ETo enhance tissue repair and regeneration following a traumatic injury, the researchers are focusing their efforts on stem cells. Even though stem cells have tremendous potential for repairing such defects, effective methods do not yet exist for delivering them to an injury site and of ensuring that they survive and remain at that site long enough to impact the regeneration process.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022Clinicians currently inject stem cells into a vein and hope that the cells will migrate to sites of injury and remain at those sites long enough to participate in the repair process. While some cells certainly do migrate to injury sites, the actual percentage is very small and those that arrive at the site do not remain to engraft with the host tissue,\u0022 explained Boyan.\u003C\/p\u003E\n\u003Cp\u003EThis limited effect may be the result of the injection process, according to Boyan, so researchers in the center are developing ways to protect the cells from damaging forces they might encounter when inserted into the body.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022Studies in our laboratory have shown that when stem cells are encapsulated in microbeads, they can be injected by needle without loss of cell viability and they remain at the injury site for at least two months,\u0022 said Boyan.\n\u003C\/p\u003E\n\u003Cp\u003EProtecting the cells during insertion is just the first step toward improved tissue repair. The researchers must also examine whether the stem cells will turn into cells typical of the implanted tissue and if they produce or should be paired with molecules that can enhance the healing of the implanted tissues.\n\u003C\/p\u003E\n\u003Cp\u003ECenter researchers are also investigating whether bone marrow-derived stem cells can be used in the body to heal large defects in bone and cartilage if they are inserted in fiber mesh scaffolds and silk sponges during a surgical procedure.\n\u003C\/p\u003E\n\u003Cp\u003EAdditional projects in the center include assessing tissue viability, preventing the growth of bone in the soft tissues of the body and improving pre-hospital care of orthopedic injuries. Since effective treatment of traumatic injuries is an important goal for the general public as well as the military population, the researchers also hope to adapt their technologies for use in hospitals.\n\u003C\/p\u003E\n\u003Cp\u003EOther researchers in the center include Ravi Bellamkonda, a professor in the Coulter Department; Andres Garcia, the Woodruff Faculty Fellow in the Woodruff School of Mechanical Engineering; Robert Taylor, a professor in the Coulter Department and Emory\u0027s Division of Cardiology; Zvi Schwartz, a visiting professor in the Coulter Department; and U.S. Army surgical medicine consultants Michael Yaszemski and David Cohen.\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EResearch News \u0026amp; Publications Office\u003Cbr \/\u003E\nGeorgia Institute of Technology\u003Cbr \/\u003E\n75 Fifth Street, N.W., Suite 100\u003Cbr \/\u003E\nAtlanta, Georgia  30308  USA\n\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003EMedia Relations Contacts: Abby Vogel (404-385-3364); E-mail: (\u003Ca href=\u0022mailto:avogel@gatech.edu\u0022\u003Eavogel@gatech.edu\u003C\/a\u003E) or John Toon (404-894-6986); E-mail: (\u003Ca href=\u0022mailto:jtoon@gatech.edu\u0022\u003Ejtoon@gatech.edu\u003C\/a\u003E).\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EWriter:\u003C\/strong\u003E Abby Vogel\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Musculoskeletal Biology and Regenerative Medicine Expertise are Keys"}],"field_summary":[{"value":"The new Georgia Tech Center for Advanced Bioengineering for Soldier Survivability is working to quickly move tools that are clinically valuable, safe and effective from laboratories to use in military trauma centers.","format":"limited_html"}],"field_summary_sentence":[{"value":"New center aims to improve recovery of severely-injured soldiers"}],"uid":"27206","created_gmt":"2009-05-26 00:00:00","changed_gmt":"2016-10-08 03:03:14","author":"Abby Vogel Robinson","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-05-26T00:00:00-04:00","iso_date":"2009-05-26T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"46313":{"id":"46313","type":"image","title":"Barbara Boyan","body":null,"created":"1449174375","gmt_created":"2015-12-03 20:26:15","changed":"1475894416","gmt_changed":"2016-10-08 02:40:16","alt":"Barbara Boyan","file":{"fid":"101089","name":"toy61295.jpg","image_path":"\/sites\/default\/files\/images\/toy61295_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/toy61295_0.jpg","mime":"image\/jpeg","size":1083074,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/toy61295_0.jpg?itok=XMwONj2V"}},"46314":{"id":"46314","type":"image","title":"bone defect","body":null,"created":"1449174401","gmt_created":"2015-12-03 20:26:41","changed":"1475894416","gmt_changed":"2016-10-08 02:40:16","alt":"bone defect","file":{"fid":"101090","name":"tcq61295.jpg","image_path":"\/sites\/default\/files\/images\/tcq61295_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tcq61295_0.jpg","mime":"image\/jpeg","size":35753,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tcq61295_0.jpg?itok=fbnt2zCT"}},"46315":{"id":"46315","type":"image","title":"Robert Guldberg","body":null,"created":"1449174401","gmt_created":"2015-12-03 20:26:41","changed":"1475894416","gmt_changed":"2016-10-08 02:40:16","alt":"Robert Guldberg","file":{"fid":"101091","name":"tgx61295.jpg","image_path":"\/sites\/default\/files\/images\/tgx61295_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/tgx61295_0.jpg","mime":"image\/jpeg","size":1098693,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/tgx61295_0.jpg?itok=RfWhTAre"}}},"media_ids":["46313","46314","46315"],"related_links":[{"url":"http:\/\/www.bme.gatech.edu\/facultystaff\/faculty_record.php?id=48","title":"Barbara Boyan"},{"url":"http:\/\/www.me.gatech.edu\/faculty\/guldberg.shtml","title":"Robert Guldberg"},{"url":"http:\/\/www.bme.gatech.edu\/","title":"Wallace H. Coulter Department of Biomedical Engineering"},{"url":"http:\/\/www.me.gatech.edu\/","title":"George W. Woodruff School of Mechanical Engineering"}],"groups":[{"id":"1188","name":"Research Horizons"}],"categories":[{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"147","name":"Military Technology"},{"id":"149","name":"Nanotechnology and Nanoscience"},{"id":"135","name":"Research"}],"keywords":[{"id":"534","name":"barbara"},{"id":"277","name":"Biology"},{"id":"530","name":"bone"},{"id":"535","name":"boyan"},{"id":"532","name":"cell"},{"id":"531","name":"defect"},{"id":"528","name":"device"},{"id":"537","name":"goldberg"},{"id":"521","name":"injury"},{"id":"527","name":"medical"},{"id":"524","name":"medicine"},{"id":"525","name":"military"},{"id":"522","name":"muskuloskeletal"},{"id":"523","name":"regenerative"},{"id":"536","name":"robert"},{"id":"170849","name":"soldier"},{"id":"167258","name":"STEM"},{"id":"533","name":"tissue"},{"id":"526","name":"trauma"},{"id":"529","name":"wound"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EAbby Vogel\u003C\/strong\u003E\u003Cbr \/\u003EResearch News and Publications\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=avogel6\u0022\u003EContact Abby Vogel\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-385-3364\u003C\/strong\u003E","format":"limited_html"}],"email":["avogel@gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56444":{"#nid":"56444","#data":{"type":"news","title":"Video Archive - Engineering Stem Cell Technologies","body":[{"value":"\u003Cp\u003E\u003Cstrong\u003ETodd McDevitt, PhD - Assistant Professor, Wallace H. Coulter Department of Biomedical Engineering\u003C\/strong\u003E\n\u003C\/p\u003E\n\u003Cp\u003EAbstract: Stem cells are poised to stimulate significant advances in regenerative medicine therapies and in vitro cell-based diagnostics based upon their inherent ability to differentiate into an array of cell phenotypes.  Beyond cell replacement technologies, stem cells may also serve as a unique source of potent morphogenic factors capable of improving the wound healing of injured tissues and treatment of chronic diseases.  Thus, our laboratory is focused on the engineering of innovative approaches to translate the potential of stem cells into effective cellular and molecular technologies for regenerative medicine.  In order to improve the efficiency and homogeneity of directed differentiation strategies, we are developing biomaterials-based approaches to spatiotemporally control the presentation of molecular cues within the stem cell microenvironment that influence morphogenesis.  The ability of hydrodynamic forces to manipulate environmental conditions and modulate stem cell fate is also being examined as a novel, scalable means to direct differentiated cell phenotypes.  In addition to directing stem cell differentiation, we also seek to develop novel regenerative molecular therapies from morphogens uniquely produced by stem cells.  For this reason, we are assessing the production of morphogenic factors by pluripotent embryonic stem cells undergoing differentiation and producing stem cell-derived matrices for acellular tissue therapies.  It is expected that engineering of stem cell differentiation and derivation of stem cell biotherapeutics will yield fresh insights into stem cell and developmental biology, as well as new regenerative medicine therapies and in vitro diagnostic technologies.\n\u003C\/p\u003E\n\u003Cp\u003E\u003Ca href=\u0027http:\/\/mcdevitt.bme.gatech.edu\/\u0027\u003EVisit the McDevitt ESCT Laboratory\u003C\/a\u003E\n\u003C\/p\u003E\n\u003Cp\u003ETo view video:  \u003Ca href=\u0027http:\/\/smartech.gatech.edu\/handle\/1853\/27813\u0027\u003EMcDevitt - Breakfast Club Seminar\u003C\/a\u003E\n\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":[{"value":"Todd McDevitt, PhD - IBB Breakfast Club Seminar"}],"field_summary":[{"value":"Engineering Stem Cell Technologies - A video library of Todd McDevitt giving an overview of his laboratory at the Institute for Bioengineering and Bioscience.","format":"limited_html"}],"field_summary_sentence":[{"value":"Engineering Stem Cell Technologies - IBB Breakfast Club Seminar"}],"uid":"27195","created_gmt":"2009-04-29 00:00:00","changed_gmt":"2016-10-08 03:06:11","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2009-04-21T00:00:00-04:00","iso_date":"2009-04-21T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"related_links":[{"url":"http:\/\/smartech.gatech.edu\/handle\/1853\/27813","title":"View Video Here"}],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"134","name":"Student and Faculty"}],"keywords":[{"id":"569","name":"bioengineering"},{"id":"249","name":"Biomedical Engineering"},{"id":"762","name":"Bioscience"},{"id":"759","name":"Breakfast Club"},{"id":"516","name":"engineering"},{"id":"248","name":"IBB"},{"id":"167413","name":"Stem Cell"},{"id":"760","name":"Todd McDevitt"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EColly Mitchell\u003C\/strong\u003E\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=cmitchell6\u0022\u003EContact Colly Mitchell\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-894-5982\u003C\/strong\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56402":{"#nid":"56402","#data":{"type":"news","title":"McDevitt Research Highlighted in Nature Materials","body":[{"value":"\u003Cp\u003E\u003Cstrong\u003E\u0022Materials in a Cellular World\u0022\n\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EBiological factors are not the only influence on stem-cell behaviour\u003C\/strong\u003E\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"Following his presentation at the World Biomaterials Congress in Amsterdam in May 2008, Todd McDevitt, PhD, research is highlighted in Nature Materials Journal.  \u0022Materials in a Cellular World\u0022","format":"limited_html"}],"field_summary_sentence":[{"value":"McDevitt Research Highlighted in Nature Materials"}],"uid":"27195","created_gmt":"2008-08-28 00:00:00","changed_gmt":"2016-10-08 03:06:06","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2008-08-01T00:00:00-04:00","iso_date":"2008-08-01T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"140","name":"Cancer Research"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"3024","name":"biomaterials"},{"id":"6217","name":"McDevitt"},{"id":"9518","name":"Nature Materials"},{"id":"1489","name":"Regenerative Medicine"},{"id":"167413","name":"Stem Cell"},{"id":"4891","name":"Tissue Engineering"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EColly Mitchell\u003C\/strong\u003E\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=cmitchell6\u0022\u003EContact Colly Mitchell\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-894-5982\u003C\/strong\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}},"56392":{"#nid":"56392","#data":{"type":"news","title":"Todd McDevitts Research Highlighted on Live Science","body":[{"value":"\u003Cp\u003ELive Science, an NSF supported online publication, features the stem cell research of Todd McDevitt, PhD.\n\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EBehind the Scenes:  Stem Cell Research Goes Beyond Biology\u003C\/strong\u003E\n\u003C\/p\u003E\n\u003Cp\u003ETo read article: \u003Ca href=\u0027http:\/\/www.livescience.com\/space\/080523-bts-mcdevitt-stem-cells.html\u0027\u003Ehttp:\/\/www.livescience.com\/space\/080523-bts-mcdevitt-stem-cells.html\u003C\/a\u003E \u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"Behind the Scenes:  Stem Cell Research Goes Beyond Biology","format":"limited_html"}],"field_summary_sentence":[{"value":"Todd McDevitt"}],"uid":"27195","created_gmt":"2008-05-27 00:00:00","changed_gmt":"2016-10-08 03:06:06","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2008-05-23T00:00:00-04:00","iso_date":"2008-05-23T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"groups":[{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"134","name":"Student and Faculty"},{"id":"135","name":"Research"}],"keywords":[{"id":"2156","name":"ALS"},{"id":"9499","name":"Alzheimers"},{"id":"2097","name":"arthritis"},{"id":"569","name":"bioengineering"},{"id":"277","name":"Biology"},{"id":"249","name":"Biomedical Engineering"},{"id":"1503","name":"Biotechnology"},{"id":"363","name":"NSF"},{"id":"9505","name":"Organ Repair"},{"id":"9504","name":"Parkinsons"},{"id":"170899","name":"spinal cord injury"},{"id":"167413","name":"Stem Cell"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003EColly Mitchell\u003C\/strong\u003E\u003Cbr \/\u003EParker H. Petit Institute for Bioengineering and Bioscience\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=cmitchell6\u0022\u003EContact Colly Mitchell\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-894-5982\u003C\/strong\u003E","format":"limited_html"}],"email":["colly.mitchell@ibb.gatech.edu"],"slides":[],"orientation":[],"userdata":""}}}